Elicio Therapeutics Inc. Capital Reinvestment Ratio
Elicio Therapeutics Inc. capital reinvestment ratio. Elicio Therapeutics Inc. (ELTX) has a Capital Reinvestment Ratio of 0.09x as of June 2022, meaning it reinvests 0% of its operating cash flow ($6.14 Million) in capital expenditures ($559.00K). Check Elicio Therapeutics Inc. (ELTX) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Elicio Therapeutics Inc. (2012–2013)
Capital reinvestment ratio of Elicio Therapeutics Inc. from 2012 to 2013. This chart tracks Elicio Therapeutics Inc.'s Capital Reinvestment Ratio across 2 annual periods. Also explore ELTX net asset momentum to track the company's year-over-year net asset growth rate.
Elicio Therapeutics Inc. Capital Reinvestment Ratio by Year (2012–2013)
Elicio Therapeutics Inc. capital reinvestment ratio by year from 2012 to 2013. For the full cash flow conversion analysis, see cash flow conversion of Elicio Therapeutics Inc..
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2013 | 0.01x | $1.89 Million | $17.57K | ▼ -79.3% |
| 2012 | 0.04x | $1.07 Million | $47.73K | — |